Form 8-K - Current report:
SEC Accession No. 0001641172-25-013051
Filing Date
2025-05-30
Accepted
2025-05-30 16:30:51
Documents
12
Period of Report
2025-05-30
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 43146
  Complete submission text file 0001641172-25-013051.txt   210209

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE imnn-20250530.xsd EX-101.SCH 3008
3 XBRL LABEL FILE imnn-20250530_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE imnn-20250530_pre.xml EX-101.PRE 22354
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3688
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Filer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15911 | Film No.: 251011465
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)